Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 25Genitourinary 19Gastrointestinal 16Other hematologic neoplasm 15Lymphoid 12Dermatologic 6Myeloid 5CNS 5Gynecologic 4Classical hematology 3Other 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Other neoplasm 1Endocrine 1

Conditions

Vitamin D Deficiency 1Multiple Myeloma 1

Interventions

Dexamethasone 871Bortezomib 457Lenalidomide 456Cyclophosphamide 365Melphalan 272Calcium Dobesilate 263daratumumab 234pomalidomide 208carfilzomib 182fludarabine phosphate 140fludarabine 136Thalidomide 125Peripheral Blood Stem Cell Transplantation 119Filgrastim 114ixazomib 93Mycophenolic Acid 90Granulocyte Colony-Stimulating Factor 89Whole-Body Irradiation 87Busulfan 87dexamethasone acetate 86Tacrolimus 78dexamethasone 21-phosphate 74isatuximab 69Cyclosporine 68auricularum 67Prednisone 65elotuzumab 58belantamab mafodotin 57Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholecalciferol × Plasma cell × Clear all
NCT05846880 2025-04-08

VitD3 Supplementation in Patients With Multiple Myeloma

Augusta University

Phase EARLY_PHASE1 Recruiting
100 enrolled
Plasma cell

Multiple Myeloma, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡